P-007 第30天(而非更早)的绝对淋巴细胞计数和早期CRS可预测对替卡单抗的延迟反应:美国骨髓瘤免疫疗法联盟的研究结果

IF 2.7 4区 医学 Q2 HEMATOLOGY Clinical Lymphoma, Myeloma & Leukemia Pub Date : 2024-09-01 DOI:10.1016/S2152-2650(24)01910-4
Rahul Banerjee, Gurbakhash Kaur, Beatrice Razzo, Andrew Portuguese, Surbhi Sidana, Tiffany Richards, Ariel Grajales-Cruz, Shambavi Richard, Leyla Shune, Jack Khouri, Danai Dima, Hans Lee, Krina Patel, Mariola Vazquez-Martinez, Doris Hansen, James Davis, Hamza Hashmi, Shebli Atrash, Christopher Ferreri, Kelley Julian, Alfred Garfall
{"title":"P-007 第30天(而非更早)的绝对淋巴细胞计数和早期CRS可预测对替卡单抗的延迟反应:美国骨髓瘤免疫疗法联盟的研究结果","authors":"Rahul Banerjee, Gurbakhash Kaur, Beatrice Razzo, Andrew Portuguese, Surbhi Sidana, Tiffany Richards, Ariel Grajales-Cruz, Shambavi Richard, Leyla Shune, Jack Khouri, Danai Dima, Hans Lee, Krina Patel, Mariola Vazquez-Martinez, Doris Hansen, James Davis, Hamza Hashmi, Shebli Atrash, Christopher Ferreri, Kelley Julian, Alfred Garfall","doi":"10.1016/S2152-2650(24)01910-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S43-S44"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P-007 Absolute Lymphocyte Count at Day 30 (Not Earlier) and Early CRS Predict Delayed Responses to Teclistamab: Results From the US Myeloma Immunotherapy Consortium\",\"authors\":\"Rahul Banerjee, Gurbakhash Kaur, Beatrice Razzo, Andrew Portuguese, Surbhi Sidana, Tiffany Richards, Ariel Grajales-Cruz, Shambavi Richard, Leyla Shune, Jack Khouri, Danai Dima, Hans Lee, Krina Patel, Mariola Vazquez-Martinez, Doris Hansen, James Davis, Hamza Hashmi, Shebli Atrash, Christopher Ferreri, Kelley Julian, Alfred Garfall\",\"doi\":\"10.1016/S2152-2650(24)01910-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"24 \",\"pages\":\"Pages S43-S44\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265024019104\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265024019104","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
P-007 Absolute Lymphocyte Count at Day 30 (Not Earlier) and Early CRS Predict Delayed Responses to Teclistamab: Results From the US Myeloma Immunotherapy Consortium
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
3.70%
发文量
1606
审稿时长
26 days
期刊介绍: Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
期刊最新文献
Clinical Characteristics and Survival Outcomes of Patients With Primary and Secondary Plasma Cell Leukemia According to the 2021 Definition: A Single Center Retrospective Study. Incidence, Risk Factors and Early Prediction of Doxorubicin-Induced Cardiotoxicity by Global Longitudinal Strain and Cardiac Biomarkers in Indian Patients With Lymphoma: A Prospective Observational Study. Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France. First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium. Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1